Monopar Therapeutics (MNPR) Short term Debt (2020)
Monopar Therapeutics (MNPR) has disclosed Short term Debt for 1 consecutive years, with $67772.0 as the latest value for Q3 2020.
Monopar Therapeutics (MNPR) has disclosed Short term Debt for 1 consecutive years, with $67772.0 as the latest value for Q3 2020.